Froome fails doping test
Froome fails doping test
Froome won his fourth Tour title this year and followed it with a victory at the Vuelta. But Team Sky said yesterday that Froome, who has not been suspended, had a concentration of asthma drug salbutamol two times higher than the World Anti-Doping Agency’s permitted levels.
“Analysis indicated the presence of salbutamol at a concentration of 2,000 nanograms per milliliter (ng/ml), compared with the WADA threshold of 1,000 ng/ml,” Team Sky said.
Team Sky said it has been informed by the International Cycling Union that the urine test was taken on Sept. 7, during the three-week Spanish Vuelta.
Froome said the UCI has asked him to provide information about the failed test, which was taken after Stage 18.
Froome’s use of asthma medication has been well documented, and the Kenyan-born rider has often been spotted using inhalers in the peloton. He has repeatedly faced questions on whether he is a clean rider, especially during the Tour de France, and has always denied wrongdoing.
Salbutamol is a drug that helps expand lung capacity and can be used as a performance-enhancing drug to increase endurance. Commonly marketed as Ventolin, salbutamol is classified as a beta-2 agonist and WADA allows it to be taken through inhalation only, in limited amounts.
Sky said Froome had to take an increased dosage of salbutamol without exceeding the permissible dose after he “experienced acute asthma symptoms” during the final week of the Vuelta.
If found guilty of doping, the 32-year-old Froome could lose his Vuelta title and be suspended for a long period. Sprinter Alessandro Petacchi was suspended for one year for testing positive for salbutamol during the 2007 Giro d’Italia.
Vuelta organizers said they will not comment until they receive official notification about the case.
Froome was expected to attempt to join cycling greats Eddy Merckx, Bernard Hinault and Miguel Indurain on the list of five-time Tour de France champions in July. Lance Armstrong won seven titles, but all of them were stripped because of doping.
Team Sky has been dominating the field at the Tour de France in recent years, but has been targeted by doping accusations. Britain’s anti-doping agency last month closed an investigation into the team without bringing charges. The case centered on the contents of a medical package dispatched to former Tour champion Bradley Wiggins at a key pre-Tour race in 2011.
Team Sky was established in 2009 by Dave Brailsford, the man behind Britain’s 14 medals at the 2008 Beijing Olympics, with the target of producing the country’s first Tour champion — a feat accomplished by Wiggins in 2012. Froome, his former teammate, has taken over since as Britain’s most successful road rider.
After successfully defending his Tour de France title in July, Froome went on to win the Spanish Vuelta for the first time.
“My asthma got worse at the Vuelta so I followed the team doctor’s advice to increase my salbutamol dosage,” Froome said. “As always, I took the greatest care to ensure that I did not use more than the permissible dose. I take my leadership position in my sport very seriously. The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires.”
The UCI said in a statement that Froome’s “B” sample confirmed the result, but stressed that “the presence of a specified substance such as salbutamol in a sample does not result in the imposition of such mandatory provisional suspension against the rider.”
Sky said the abnormal result does not mean Froome has breached anti-doping rules and Brailsford insisted he has the “utmost confidence that Chris followed the medical guidance in managing his asthma symptoms, staying within the permissible dose for salbutamol.”
Froome said last month that he wants to ride in next year’s Giro d’Italia in an attempt to win his third Grand Tour in a row. A victory at the Italian race would make him the seventh rider to win all three Grand Tours, and only the third to hold the three titles at the same time.
Mohamed Salah named Premier League’s best player of the year at PFA awards
- Egyptian superstar currently has 30 Premier League goals this season
- Salah beat the likes of De Bruyne and Kane to the award
LONDON: Mohamed Salah was crowned the Premier League’s Players’ Player of the Year on Sunday, with his incredible 41-goal debut season at Liverpool beating out strong competition from Manchester City’s Kevin de Bruyne.
“It’s a big honor. I’ve worked hard and I’m very happy to win it,” Salah said at the ceremony on Sunday evening.
Salah matched a Premier League record tally for a single season by scoring his 31st league goal of the campaign in a 2-2 draw at West Brom on Saturday.
“You’re comparing your name with some great names,” he said, on the prospect of breaking the record. “To break the Premier League record is something huge in England and all over in the world.
“There are still three games to go. I want to break this record.”
Salah has also netted seven times in eight Champions League games, including in both legs of Liverpool’s 5-1 quarter-final thrashing of City, to carry his side to a first semifinal for a decade.
De Bruyne showed why he had been many people’s early-season favorite for the prize with an incredible long-range strike for his 12th goal of the season to go with a league-high number of assists as champions City thrashed Swansea 5-0 on Sunday.
“From my point of view when you are analizing 10 months, there is no player better than him,” said City manager Pep Guardiola of the Belgian midfielder.
“Maybe there are numbers better but for me he was the best. But it is my opinion, the opinions of the players could be different. But in the end, in summer time he will be at home being champion.”
City did pick up a prize from the PFA gala in central London on Sunday, though, as Leroy Sane won the Young Player of the Year.
Sane, another City team-mate David Silva, De Bruyne, Manchester United goalkeeper David De Gea and Tottenham striker Harry Kane were the other five nominees for the main prize.